Your browser doesn't support javascript.
loading
Therapeutic siRNA: state of the art.
Hu, Bo; Zhong, Liping; Weng, Yuhua; Peng, Ling; Huang, Yuanyu; Zhao, Yongxiang; Liang, Xing-Jie.
Affiliation
  • Hu B; School of Life Science, Advanced Research Institute of Multidisciplinary Science, Institute of Engineering Medicine, Key Laboratory of Molecular Medicine and Biotherapy, Beijing Institute of Technology, 100081, Beijing, People's Republic of China.
  • Zhong L; National Center for International Biotargeting Theranostics, Guangxi Key Laboratory of Biotargeting Theranostics, Collaborative Innovation Center for Targeting Tumor Theranostics, Guangxi Medical University, 530021, Guangxi, People's Republic of China.
  • Weng Y; School of Life Science, Advanced Research Institute of Multidisciplinary Science, Institute of Engineering Medicine, Key Laboratory of Molecular Medicine and Biotherapy, Beijing Institute of Technology, 100081, Beijing, People's Republic of China.
  • Peng L; Aix-Marseille University, CNRS, Centre Interdisciplinaire de Nanoscience de Marseille (CINaM), Equipe Labellisée Ligue Contre le Cancer, 13288, Marseille, France.
  • Huang Y; School of Life Science, Advanced Research Institute of Multidisciplinary Science, Institute of Engineering Medicine, Key Laboratory of Molecular Medicine and Biotherapy, Beijing Institute of Technology, 100081, Beijing, People's Republic of China. yyhuang@bit.edu.cn.
  • Zhao Y; National Center for International Biotargeting Theranostics, Guangxi Key Laboratory of Biotargeting Theranostics, Collaborative Innovation Center for Targeting Tumor Theranostics, Guangxi Medical University, 530021, Guangxi, People's Republic of China. yongxiang_zhao@126.com.
  • Liang XJ; Chinese Academy of Sciences (CAS), Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, 100190, Beijing, People's Republic of China. liangxj@nanoctr.cn.
Signal Transduct Target Ther ; 5(1): 101, 2020 06 19.
Article in En | MEDLINE | ID: mdl-32561705

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrrolidines / Acetylgalactosamine / RNA, Small Interfering / Genetic Diseases, Inborn Limits: Humans Language: En Journal: Signal Transduct Target Ther Year: 2020 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrrolidines / Acetylgalactosamine / RNA, Small Interfering / Genetic Diseases, Inborn Limits: Humans Language: En Journal: Signal Transduct Target Ther Year: 2020 Document type: Article Country of publication: